🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study will be to evaluate the efficacy of gef...
Status
Completed
Location
The First Affiliated Hospital of Fujian Medical University ( Site 5017)
Start Date
2019-05-17
Trial ID
NCT04525885
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of gefapix...
Status
Completed
Location
Center for Clinical Trials, LLC ( Site 0021)
Start Date
2020-05-10
Trial ID
NCT04193176
Treatments Being Tested
The main objectives of this study will be to evaluate the efficacy of gefap...
Status
Completed
Location
Research Solutions of Arizona PC ( Site 0036)
Start Date
2018-03-14
Trial ID
NCT03449134
Treatments Being Tested
This estimation study (no hypotheses) will evaluate the safety, tolerabilit...
Status
Completed
Location
Nagoya City University Hospital ( Site 3328)
Start Date
2018-03-16
Trial ID
NCT03482713
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
Status
Completed
Location
Cahaba Medical Care ( Site 0750)
Start Date
2018-09-11
Trial ID
NCT03654326
Treatments Being Tested
The primary objective of this study is to evaluate the safety of two doses ...
Status
Completed
Location
Chubu Rosai Hospital ( Site 3839)
Start Date
2018-10-31
Trial ID
NCT03696108
Treatments Being Tested
The primary objectives of this study are to evaluate the efficacy of gefapi...
Status
Completed
Location
Phoenix Medical Group ( Site 0022)
Start Date
2018-03-15
Trial ID
NCT03449147
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of gefapix...
Status
Completed
Location
Pulmonary Associates, PA ( Site 0016)
Start Date
2020-05-21
Trial ID
NCT04193202
Treatments Being Tested
The purpose of the study is to evaluate the efficacy, safety, and tolerabil...
Status
Terminated
Location
Hvivo Service Limited. Queen Mary BioEnterprises ( Site 0003)
Start Date
2018-07-04
Trial ID
NCT03569033
Treatments Being Tested